Trademark: 98097005
Word
SANGUINE
Status
Pending
Status Code
647
Status Date
Thursday, September 26, 2024
Serial Number
98097005
Mark Type
4
Filing Date
Friday, July 21, 2023

Trademark Owner History

Classifications
42 Research laboratory analysis of biospecimens for cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Research laboratory services providing biospecimen analysis, cell analysis assays, cell count, immunophenotyping, and HLA typing for use in infectious disease research. Compiling data for research purposes in the field of medical science and medical consultancy. Medical and scientific research in the fields of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology related to biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Providing an online searchable database in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology and health for scientific research purposes. Providing an online searchable database in the field of biospecimen and data collection for scientific research purposes. Providing information about medical research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, and immunology for purposes including biomarker discovery and validation, drug discovery and development, diagnostics development, and other translational applications. Providing information on the subject of scientific research in the field of biochemistry and biotechnology. Scientific laboratory services. Scientific research for medical purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications. Scientific research in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, oncology and health research. Providing biospecimen collection and data collection for scientific research purposes in the field of autoimmune diseases, genetic disorders, neurological disorders, oncology, infectious diseases, immunology, biomarker discovery and validation, drug discovery and development, diagnostics development, and translational applications

Trademark Events
Mar 25, 2024
Assigned To Examiner
Mar 25, 2024
Non-Final Action Written
Mar 25, 2024
Non-Final Action E-Mailed
Mar 25, 2024
Notification Of Non-Final Action E-Mailed
Jun 12, 2024
Correspondence Received In Law Office
Jul 25, 2023
New Application Entered
Aug 21, 2023
New Application Office Supplied Data Entered
Mar 25, 2024
Removed From Teas Plus
Jul 2, 2024
Notification Of Final Refusal Emailed
Jul 2, 2024
Final Refusal E-Mailed
Jun 12, 2024
Teas/Email Correspondence Entered
Jun 12, 2024
Teas Response To Office Action Received
Jul 2, 2024
Final Refusal Written
Aug 29, 2024
Teas/Email Correspondence Entered
Aug 29, 2024
Correspondence Received In Law Office
Aug 29, 2024
Teas Request For Reconsideration Received
Sep 26, 2024
Examiner's Amendment Entered
Sep 26, 2024
Examiners Amendment E-Mailed
Sep 26, 2024
Examiners Amendment -Written
Sep 26, 2024
Notification Of Examiners Amendment E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24